BioLife Solutions Balance Sheet Health
Financial Health criteria checks 4/6
BioLife Solutions has a total shareholder equity of $337.7M and total debt of $25.1M, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are $412.7M and $75.1M respectively.
Key information
7.4%
Debt to equity ratio
US$25.14m
Debt
Interest coverage ratio | n/a |
Cash | US$51.70m |
Equity | US$337.66m |
Total liabilities | US$75.05m |
Total assets | US$412.71m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BJX1's short term assets ($120.6M) exceed its short term liabilities ($42.2M).
Long Term Liabilities: BJX1's short term assets ($120.6M) exceed its long term liabilities ($32.9M).
Debt to Equity History and Analysis
Debt Level: BJX1 has more cash than its total debt.
Reducing Debt: BJX1's debt to equity ratio has increased from 0% to 7.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BJX1 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BJX1 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.